Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana.

PubWeight™: 1.95‹?› | Rank: Top 2%

🔗 View Article (PMID 15844067)

Published in Clin Infect Dis on April 12, 2005

Authors

Pratima L Raghunathan1, Ellen A S Whitney, Kwame Asamoa, Ymkje Stienstra, Thomas H Taylor, George K Amofah, David Ofori-Adjei, Karen Dobos, Jeannette Guarner, Stacey Martin, Sonal Pathak, Erasmus Klutse, Samuel Etuaful, Winette T A van der Graaf, Tjip S van der Werf, C H King, Jordan W Tappero, David A Ashford

Author Affiliations

1: National Center for Infectious Diseases, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA. pgr4@cdc.gov.

Articles citing this

Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl Trop Dis (2010) 2.98

Distribution of Mycobacterium ulcerans in buruli ulcer endemic and non-endemic aquatic sites in Ghana. PLoS Negl Trop Dis (2008) 2.16

Risk factors for buruli ulcer: a case control study in Cameroon. PLoS Negl Trop Dis (2007) 1.90

Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors. PLoS Negl Trop Dis (2010) 1.89

Integrated assessment of artisanal and small-scale gold mining in Ghana--part 1: human health review. Int J Environ Res Public Health (2015) 1.78

Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans. Nat Rev Microbiol (2009) 1.77

Risk factors for Mycobacterium ulcerans infection, southeastern Australia. Emerg Infect Dis (2007) 1.53

Aquatic invertebrates as unlikely vectors of Buruli ulcer disease. Emerg Infect Dis (2008) 1.52

Geographic distribution, age pattern and sites of lesions in a cohort of Buruli ulcer patients from the Mapé Basin of Cameroon. PLoS Negl Trop Dis (2013) 1.42

Buruli ulcer disease prevalence in Benin, West Africa: associations with land use/cover and the identification of disease clusters. Int J Health Geogr (2008) 1.33

Detection of Mycobacterium ulcerans in the environment predicts prevalence of Buruli ulcer in Benin. PLoS Negl Trop Dis (2012) 1.27

A Landscape-based model for predicting Mycobacterium ulcerans infection (Buruli Ulcer disease) presence in Benin, West Africa. Ecohealth (2008) 1.26

Landscape diversity related to Buruli ulcer disease in Côte d'Ivoire. PLoS Negl Trop Dis (2008) 1.18

Family relationship, water contact and occurrence of Buruli ulcer in Benin. PLoS Negl Trop Dis (2010) 1.16

Mycobacterium ulcerans ecological dynamics and its association with freshwater ecosystems and aquatic communities: results from a 12-month environmental survey in Cameroon. PLoS Negl Trop Dis (2014) 1.13

Tuberculosis infection in Zambia: the association with relative wealth. Am J Trop Med Hyg (2009) 1.13

Persistent association of Mycobacterium ulcerans with West African predaceous insects of the family belostomatidae. Appl Environ Microbiol (2008) 1.11

Association between footwear use and neglected tropical diseases: a systematic review and meta-analysis. PLoS Negl Trop Dis (2014) 1.08

Interaction of Mycobacterium ulcerans with mosquito species: implications for transmission and trophic relationships. Appl Environ Microbiol (2010) 1.05

Adequate wound care and use of bed nets as protective factors against Buruli Ulcer: results from a case control study in Cameroon. PLoS Negl Trop Dis (2011) 1.04

A qualitative study exploring barriers related to use of footwear in rural highland ethiopia: implications for neglected tropical disease control. PLoS Negl Trop Dis (2013) 1.00

Impact of human immunodeficiency virus on the severity of buruli ulcer disease: results of a retrospective study in cameroon. Open Forum Infect Dis (2014) 1.00

Buruli-ulcer induced disability in ghana: a study at apromase in the ashanti region. Plast Surg Int (2012) 0.96

Findings from a buruli ulcer mouse model study. Ghana Med J (2005) 0.95

Buruli ulcer in South Western Nigeria: a retrospective cohort study of patients treated in Benin. PLoS Negl Trop Dis (2015) 0.92

Source tracking Mycobacterium ulcerans infections in the Ashanti region, Ghana. PLoS Negl Trop Dis (2015) 0.90

Risk factors for buruli ulcer in Ghana-a case control study in the Suhum-Kraboa-Coaltar and Akuapem South Districts of the eastern region. PLoS Negl Trop Dis (2014) 0.90

Perceptions on the effectiveness of treatment and the timeline of Buruli ulcer influence pre-hospital delay reported by healthy individuals. PLoS Negl Trop Dis (2013) 0.88

Mycobacterium ulcerans infection (Buruli ulcer) on the face: a comparative analysis of 13 clinically suspected cases from the Democratic Republic of Congo. Am J Trop Med Hyg (2011) 0.85

Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo. PLoS Negl Trop Dis (2015) 0.84

Experimental Survival of Mycobacterium ulcerans in Watery Soil, a Potential Source of Buruli Ulcer. Am J Trop Med Hyg (2015) 0.83

Illness meanings and experiences for pre-ulcer and ulcer conditions of Buruli ulcer in the Ga-West and Ga-South Municipalities of Ghana. BMC Public Health (2012) 0.83

Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer. PLoS Negl Trop Dis (2016) 0.80

Contours of risk: spatializing human behaviors to understand disease dynamics in changing landscapes. Ecohealth (2012) 0.80

Burden and Historical Trend of Buruli Ulcer Prevalence in Selected Communities along the Offin River of Ghana. PLoS Negl Trop Dis (2016) 0.80

Fish and amphibians as potential reservoirs of Mycobacterium ulcerans, the causative agent of Buruli ulcer disease. Infect Ecol Epidemiol (2013) 0.79

Environmental transmission of Mycobacterium ulcerans drives dynamics of Buruli ulcer in endemic regions of Cameroon. Sci Rep (2015) 0.78

Mycobacterium ulcerans infection as a cause of chronic diarrhea in an AIDS patient: a case report. World J Gastroenterol (2008) 0.78

Genotyping Tools for Mycobacterium ulcerans-Drawbacks and Future Prospects. Mycobact Dis (2014) 0.77

Socio-Environmental Factors Associated with the Risk of Contracting Buruli Ulcer in Tiassalé, South Côte d'Ivoire: A Case-Control Study. PLoS Negl Trop Dis (2016) 0.76

Snapshot fecal survey of domestic animals in rural Ghana for Mycobacterium ulcerans. PeerJ (2016) 0.75

Mycobacterium ulcerans low infectious dose and mechanical transmission support insect bites and puncturing injuries in the spread of Buruli ulcer. PLoS Negl Trop Dis (2017) 0.75

Molecular Characterization of Mycolactone Producing Mycobacteria from Aquatic Environments in Buruli Ulcer Non-Endemic Areas in Côte d'Ivoire. Int J Environ Res Public Health (2017) 0.75

A Community Based Study on the Mode of Transmission, Prevention and Treatment of Buruli Ulcers in Southwest Cameroon: Knowledge, Attitude and Practices. PLoS One (2016) 0.75

Application of geographical information system (GIS) technology in the control of Buruli ulcer in Ghana. BMC Public Health (2014) 0.75

Environmental and Behavioral Drivers of Buruli Ulcer Disease in Selected Communities Along the Densu River Basin of Ghana: A Case-Control Study. Am J Trop Med Hyg (2017) 0.75

Articles by these authors

A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med (2012) 27.84

Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis (2007) 10.66

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis (2006) 7.98

Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol (2005) 7.88

Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83

Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog (2008) 6.07

Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med (2006) 5.42

Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23

Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet (2010) 5.02

Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med (2005) 4.69

Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog (2009) 4.56

Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet (2009) 4.33

Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med (2005) 4.05

Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med (2013) 3.51

U.S. outpatient antibiotic prescribing, 2010. N Engl J Med (2013) 3.49

Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis (2002) 3.41

Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol (2005) 3.29

Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. PLoS One (2011) 3.27

Mental health problems among adults in tsunami-affected areas in southern Thailand. JAMA (2006) 3.25

Cholera surveillance during the Haiti epidemic--the first 2 years. N Engl J Med (2013) 3.19

Antimicrobial-resistant nocardia isolates, United States, 1995-2004. Clin Infect Dis (2010) 3.15

Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med (2010) 3.04

Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol (2003) 3.01

A long-term prospective population pharmacokinetic study on imatinib plasma concentrations in GIST patients. Clin Cancer Res (2012) 2.95

Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis (2002) 2.76

Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases. Endocr Relat Cancer (2007) 2.63

Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One (2010) 2.59

Evidence of a previously undocumented epidemic of HIV infection among men who have sex with men in Bangkok, Thailand. AIDS (2005) 2.58

Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. Clin Infect Dis (2009) 2.36

Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol (2002) 2.36

Beliefs and attitudes toward Buruli ulcer in Ghana. Am J Trop Med Hyg (2002) 2.30

Mycobacterium ulcerans disease. Bull World Health Organ (2005) 2.30

Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J Infect Dis (2004) 2.29

A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. J Infect Dis (2005) 2.26

Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Antimicrob Agents Chemother (2007) 2.22

Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol (2004) 2.20

Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study. J Clin Oncol (2005) 2.14

Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol (2003) 2.11

Epidemiologic response to anthrax outbreaks: field investigations, 1950-2001. Emerg Infect Dis (2002) 2.08

Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. J Clin Microbiol (2011) 2.07

From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy. Lancet Infect Dis (2007) 2.05

Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand. J Acquir Immune Defic Syndr (2008) 2.05

Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand. Emerg Infect Dis (2007) 2.04

Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis (2002) 2.02

First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00

Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog (2012) 2.00

HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect Dis (2009) 2.00

Symptoms of posttraumatic stress disorder and depression among children in tsunami-affected areas in southern Thailand. JAMA (2006) 1.98

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA (2013) 1.97

CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ (2011) 1.96

Inactivation of Bacillus anthracis spores. Emerg Infect Dis (2003) 1.96

Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr (2011) 1.95

Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso. Am J Trop Med Hyg (2006) 1.92

Elimination of cholera transmission in Haiti and the Dominican Republic. Lancet (2012) 1.91

Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995-1998. Emerg Infect Dis (2002) 1.89

Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy. Malar J (2009) 1.85

Histopathologic features of Mycobacterium ulcerans infection. Emerg Infect Dis (2003) 1.84

Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET. Nucl Med Commun (2004) 1.84

Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco. PLoS One (2011) 1.84

HIV infection among men who have sex with men in Kampala, Uganda--a respondent driven sampling survey. PLoS One (2012) 1.79

Prevalence of blood-borne infectious diseases in blood donors in Ghana. J Clin Microbiol (2002) 1.77

Mean glucose level is not an independent risk factor for mortality in mixed ICU patients. Intensive Care Med (2006) 1.76

Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol (2008) 1.76

Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. Clin Infect Dis (2010) 1.76

Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. Clin Infect Dis (2006) 1.76

Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg Infect Dis (2010) 1.75

Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol (2005) 1.75

Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients. Eur Respir J (2013) 1.75

Palmtop-assisted self-interviewing for the collection of sensitive behavioral data: randomized trial with drug use urine testing. Am J Epidemiol (2005) 1.72

Genetic differences in Pneumocystis isolates recovered from immunocompetent infants and from adults with AIDS: Epidemiological Implications. J Infect Dis (2005) 1.69

Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis (2008) 1.68

HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay. AIDS Res Hum Retroviruses (2003) 1.68

Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011. Emerg Infect Dis (2011) 1.68

Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort study. PLoS Med (2010) 1.67

Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients. Clin Infect Dis (2004) 1.67

Point: Surrogate end point biomarkers are likely to be limited in their usefulness in the development of cancer chemoprevention agents against sporadic cancers. Cancer Epidemiol Biomarkers Prev (2003) 1.65

Acceptability of Carraguard vaginal gel use among Thai couples. AIDS (2006) 1.65

Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psychooncology (2002) 1.64

Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization. J Immunol Methods (2008) 1.64

Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis (2011) 1.63

Multidrug-resistant tuberculosis outbreak among US-bound Hmong refugees, Thailand, 2005. Emerg Infect Dis (2008) 1.62

Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial. BMJ (2011) 1.62

Determination of regional cerebral blood flow by inhalation of 133-Xenon. Circ Res (1967) 1.62